Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects
This study has been completed.
Study NCT00823940   Information provided by GlaxoSmithKline

First Received on January 15, 2009.   Last Updated on September 11, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy Subjects
Healthy Volunteer
Interventions listed in this trial
Glucagon
GSK1362885
Glucagon + GSK1362885
Additional drug interventions recognized in this trial
Glucagon-Like Peptide 1
More general drug interventions related to this trial
Gastrointestinal Agents
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Incretins
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services